Addressing Clinicians’ Challenges and Misinformation Around Diagnosis of Alzheimer Disease

<p>Credits: 0.25 AMA PRA Category 1 Credit™</p> <p>CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/Podcast/alzheimer-disease-addressing-challenges-pt1'>https://www.pri-med.com/online-education/Podcast/alzheimer-disease-addressing-challenges-pt1</a></p> <p>Overview: Alzheimer disease (AD) is a growing concern as the population ages. Primary care clinicians are often the first to screen for and identify signs of cognitive impairment which may be due to AD. Join neurologist Gad Marshall, MD in this two-part podcast series, as he answers important questions and provides helpful tips for assessing cognitive impairment in primary care and provides insight into the current and emerging role of neuroimaging and biomarkers in the diagnosis of AD.</p> <p>The topics covered in this podcast are based on challenges and misconceptions identified from the CME/CE curriculum The Future of Alzheimer Disease: <a href='https://www.pri-med.com/online-education/curriculum/future-of-alzheimer-disease'>Early Recognition and Emerging Therapy</a>.</p>